trending Market Intelligence /marketintelligence/en/news-insights/trending/qks7L_1sTdLwMQ2391auJg2 content esgSubNav
In This List

Sanofi expands French vaccine production site

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Sanofi expands French vaccine production site

Sanofi is investing €170 million to expand a vaccine manufacturing site in Val de Reuil, France.

The new facility will allow Sanofi's vaccines unit, Sanofi Pasteur, to expand the supply of influenza vaccine VaxigripTetra, which is compliant with the World Health Organization's recommendation.

Sanofi plans to complete the expansion by 2021, subject to regulatory approvals, and will commence vaccine production in the new facility in 2022.

Sanofi Pasteur remains the sole influenza vaccine producer in France.